{
  "Variants Include": [
    {
      "Gene": "ACTA1",
      "variants": [
        {
          "HGVS": "NM_001364.5:c.247T>G",
          "cDNA Change": {
            "transcript": "NM_001364.5",
            "ref": "T",
            "alt": "G",
            "position": "247"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "D",
            "position": "83"
          },
          "Description in input context": "c.247T>G (p.Y83D)"
        }
      ]
    },
    {
      "Gene": "ACTA1",
      "variants": [
        {
          "HGVS": "NM_001364.5:c.484C>T",
          "cDNA Change": {
            "transcript": "NM_001364.5",
            "ref": "C",
            "alt": "T",
            "position": "484"
          },
          "Protein Change": {
            "ref": "S",
            "alt": "F",
            "position": "162"
          },
          "Description in input context": "c.484C>T (p.S162F)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Dominant Centronuclear Myopathy",
    "MONDO": "MONDO:0012345"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells transfected with ACTA1 mutants",
        "Description": "The experiment was conducted using HEK293 cells transiently transfected with wild-type or mutant ACTA1 constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001364.5:c.247T>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression levels were reduced by 30% compared to wild-type."
        },
        {
          "Variant": "NM_001364.5:c.484C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Protein expression levels were increased by 20% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type ACTA1 construct was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.A."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.A."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression levels greater than 100% of wild-type controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression levels less than 80% or greater than 120% of wild-type controls.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunofluorescence",
      "Material used": {
        "Material Source": "Patient-derived muscle cells",
        "Material Name": "Primary myoblasts from patients with dominant centronuclear myopathy",
        "Description": "The experiment was conducted using primary myoblasts derived from patients carrying ACTA1 mutations."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001364.5:c.247T>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "dominant-negative",
          "Result Description": "Cells showed reduced α-actinin staining compared to wild-type cells."
        },
        {
          "Variant": "NM_001364.5:c.484C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Cells showed increased α-actinin aggregation in the cytoplasm."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-actinin antibody was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells without primary antibodies were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.A."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.A."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not specified in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Staining intensity comparable to wild-type cells.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reduced or altered staining patterns compared to wild-type cells.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}